---
link: https://news.google.com/rss/articles/CBMibkFVX3lxTE9rUDVWZTdfb3dwbTZoU3VBQU40ZXdGZGhlTG9rc3Z2TGJ4NmRyNzNGNGEzLU52R25nVmhyZ1g2eHpSdm5zalIzM0Y0RklxYUJSSmlreWNqLWg0T3kwQlJObzE2cFRwUmJUV3J0RGVB?oc=5
author: 
published: Mon, 22 Dec 2025 09:14:27 GMT
tags: [News, Google, 경제]
---
# 식약처, 재발·불응성 다발골수종 치료제 '브렌랩주' 희귀신약 허가 - 팜이데일리

[원문 링크](https://news.google.com/rss/articles/CBMibkFVX3lxTE9rUDVWZTdfb3dwbTZoU3VBQU40ZXdGZGhlTG9rc3Z2TGJ4NmRyNzNGNGEzLU52R25nVmhyZ1g2eHpSdm5zalIzM0Y0RklxYUJSSmlreWNqLWg0T3kwQlJObzE2cFRwUmJUV3J0RGVB?oc=5)

## 요약/본문
<ol><li><a href="https://news.google.com/rss/articles/CBMibkFVX3lxTE9rUDVWZTdfb3dwbTZoU3VBQU40ZXdGZGhlTG9rc3Z2TGJ4NmRyNzNGNGEzLU52R25nVmhyZ1g2eHpSdm5zalIzM0Y0RklxYUJSSmlreWNqLWg0T3kwQlJObzE2cFRwUmJUV3J0RGVB?oc=5" target="_blank">식약처, 재발·불응성 다발골수종 치료제 '브렌랩주' 희귀신약 허가</a>&nbsp;&nbsp;<font color="#6f6f6f">팜이데일리</font></li><li><a href="https://news.google.com/rss/articles/CBMiT0FVX3lxTFBiOVBlSFl4Tm1oQl8zd0FlQ0dNd3JSd054ZzJkQW05Y1lSLXhnUFRYS1FPclptRDZDXzVrUkEtU2JxMGt4WEtNODVzaFJSTEU?oc=5" target="_blank">ADC 재발·불응성 다발골수종 신약 '브렌랩', 신속 심사로 '허가'</a>&nbsp;&nbsp;<font color="#6f6f6f">v.daum.net</font></li><li><a href="https://news.google.com/rss/articles/CBMiW0FVX3lxTE1KbjRJT29vNF9FbjEyTjM4bGZLelc0MS1XR0taTWdQRWdvZlQ5NVMtY0RfUUFhMnRueEFrcUZlYTZlOEVPUUsxNkdZVFYwTVNNV2lWekU4ZkwzckHSAWBBVV95cUxQZVZ3QnVIU3RPb292RU1FSTlRMTJfLUdYbHFkbzdKN2NWbXVwY2lWeVI3WjBSOXBQdTF5OFl6YktiSjdsaXJQVlVyRWIzem42aUIxanlWWkZWTk9BWkZzQUI?oc=5" target="_blank">식약처, 새 다발골수종 치료제 '브렌랩주' 허가</a>&nbsp;&nbsp;<font color="#6f6f6f">연합뉴스</font></li><li><a href="https://news.google.com/rss/articles/CBMiTkFVX3lxTFBUTzJwbVRfV0tVY2lwV3ZVUGFQMTFqUm5lam1HLVgyb3dCZUdHbWpZVFNiZVdsb0M5YjhTNC05dm5mQ093a3VBYjRjcXJFUQ?oc=5" target="_blank">식약처, 재발·불응성 다발골수종 치료제 ‘브렌랩주’ 허가</a>&nbsp;&nbsp;<font color="#6f6f6f">디지털타임스</font></li><li><a href="https://news.google.com/rss/articles/CBMiWEFVX3lxTE5MTU5scFg1Y0duUzNiNmptX3FOdm9JMUY3OXplRHllVUh2RjlrWmJVek9lWG1jUEptTVl4LTA1YUhVbjdjS0JQR2ZxRVJlU251dHhZOTkxT3g?oc=5" target="_blank">GSK, 재발･불응성 다발골수종 치료제 ‘브렌랩주’(벨란타맙 마포도틴) 국내 허가</a>&nbsp;&nbsp;<font color="#6f6f6f">헬스오</font></li></ol>
